Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I am told on ST that she is doing great and got her 6th dose of LL today.
Your statements are patently false.
Painful as it was to write, it is a beautiful and inspirational story, and a testament to the power of your love for her, in addition to a testament to the power of Leronlimab. Thank you. I wish it could be published in the opinion section by news agencies. It is a very worthy piece of writing and a true story told from personal experience.
Sound like he may be one of the 28
Is this your quote @DrWoodcockFDA? pic.twitter.com/xJqRfUmzd4
— William R (@William33308264) April 18, 2021
Very much appreciate your posts.
If Leronlimab is good enough for the ex President all citizens of the Philippines should have access to this life saving drug! Demand EUA! @cnnphilippines @cito_beltran @inquirerdotnet @ABSCBNNews @CMRamosINQ https://t.co/QBDrXntcEg
— Tom Smith (@TomSmit01069776) April 17, 2021
I hope that Cytodyn is aggressively recruiting for the OLE.
I totally agree! https://www.brainyquote.com/quotes/mark_twain_103756
We just might get something from FDA. CD12 is still recruiting as OLE continues....why is that?
That is horrible
Courtesy of PUB3jw on YMB:
ALERT -- I have two long-standing college friends who are in Senior Mgmt. at both Pfizer and Merck. Today with Merck's announcement that they will be discontinuing the advancement/development of their COVID-19 vaccine MRK-7110, I thought I'd put a call into both of them to get their current thoughts on EUAs / FDA and Vaccines vs. Therapy alternatives. To my surprise, both friends were very aware of CYDY (more specifically Leronlimab) its EUA struggles, and some of the very positive recent results. In both conversations, I was able to confirm there are "current" conversations between their respective firms and CYDY. Additionally, both apologized that for "security reasons" they really couldn't comment on the nature of the discussions but assured me things appear very positive (emphasis added) for CYDY's future. I tried hard for both of them to "clarify" their statements, but both were getting uncomfortable with going any further with respect to the topic of Leronlimab. The one comment given to me (without any details) before the end of one of the calls was "hold on to your CYDY shares." You can interpret that in many ways. Thought I'd pass this along to this Board given there are so many folks here working so hard to get Leronlimab released to the larger, struggling therapeutics market.
$3.09 +17%
And I am very happy it did help her, and I hope she continues to improve!
Plenty of FUD on Twitter
Dr. Bream posted this critique of the FDA on his Bream Medical Facebook page yesterday.
All of these countries look to the FDA for guidance for therapeutics. Our FDA has let them down.
I’ll say it again....the FDA’s cozy relationship with Big Pharma, whose drugs have all been failures in really sick COVID patients (sans Roche’s tocilizumab), has cost millions of lives worldwide.
Because all the Big Pharma companies failed, the FDA basically did nothing. Dr. Woodcock herself admitted all of the trials on actually sick patients were underpowered (the FDA signs off on trial design) when she participated in a forum with AMA President, Susan Bailey. As such, none of them were powered to hit a primary endpoint. So, basically, the therapeutic trials were a waste - UNLESS the FDA actually starts following the “safe and may be effective” criteria for an EUA. Then, other countries, who are struggling BADLY right now, can get medications like leronlimab, aviptadil, abs tocilizumab (although they have manufacturing shortfall). The FDA could also do an Operation Warp Speed for therapeutics as well!
How many people have to die for a p-value, Dr. Woodock?
So, let’s analyze the FDA’s record on COVID:
HCQ - failed EUA that was granted despite the data suggesting its failure
Plasma - failed EUA granted without any significant study showing benefit; only that if plasma is given sooner it any be more beneficial. But, at no time was a placebo-controlled trial done for its EUA. Those trials failed.
Remdesivir - failed EUA despite studies in China showing no benefit. Association with NIAID and Gilead got the goal posts moved on its study. It showed no benefit in severely ill patients and its 4 day reduction in hospitalization length didn’t hold up in larger trials.
Regeneron/Lily MABs - I told this page’s followers back in November these drugs would fail due to mutations in my talk about why leronlimab was better than bamlanivimab. And, guess what? States are now not using those drugs because the mutations rendered them useless. This will be another pretty much failed EUA. While these drugs had initial promise, much like with the vaccines, EUA without logistics made them hard to obtain. This would compounded by the need for an infusion in an overwhelmed healthcare system (which was another colossal US healthcare failure).
Baricitinib? (laughing emoji here)
As a physician, and as a human who has had a friend to die and a close friend lose his dad, what the FDA has done is indefensible, unethical, and a violation of the Hipppcratic Oath. When promising drugs have shown they’re safe, not allowing them to be used by the FDA is a violation of “first do no harm.”
It’s past time we demand better from our government. We have let the world down!
USFDA
Our FDA and NIH are medieval in their thinking.
Excellent work!
Sounds about right for a medivac helicopter.
Interesting: https://sanotize.com/covid-19/
They are dying on the street in front of hospitals too full to take them in. In Manaus it was pronounced that so many people had gotten COVID before that they had herd immunity but now it is a tragic scene.
I think things may move fast in Brazil. So many are dying there, 4000 per day with half the population of the US.
The company said it no longer believes that developing a multiple-day injection that requires administration in a healthcare setting addresses an unmet need for non-hospitalized patients.
Absolutely and Leronlimab is proven totally safe.
Bid $3.28, Ask $3.24?
Brazil does. That mutation is more contagious and deadly than the British mutation. Same with the South African variant. Both are spreading here in the USA. In Brazil, ICU’s are full and a lot of people are dying on the streets in front of the hospitals. ICU patients there now are mostly under 40.
Brazil now has more young than old COVID patients in ICUs, over 4,000 deaths every day.
https://medicalxpress.com/news/2021-04-brazil-young-covid-patients-icus.html
We are also getting anecdotal accounts that it does from partcipants in the phase 2 longhaulers trial of Leronlimab, such as “Georgia peach” on Twitter.
It’s already more than one, including their former president.